These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7369911)

  • 1. Fluorophotometry and the blood-ocular barrier in experimental systemic hypertension.
    Dutton JJ; Krupin T; Waltman SR; Koloms BA; Becker B
    Arch Ophthalmol; 1980 Apr; 98(4):731-3. PubMed ID: 7369911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescein dynamics in the eye.
    Cunha-Vaz J; Maurice D
    Doc Ophthalmol; 1969; 26():61-72. PubMed ID: 5359554
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of the blood-retinal barrier in experimental diabetes. Vitreous fluorophotometry using carboxyfluorescein and fluorescein.
    Blair NP; Jones CW; Rusin MM
    Arch Ophthalmol; 1984 Dec; 102(12):1810-4. PubMed ID: 6508620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vitreous fluorophotometry (part I)].
    Zhu XH
    Zhonghua Yan Ke Za Zhi; 1982 May; 18(3):147-52. PubMed ID: 6813070
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative determination of fluorescein in the anterior chamber and vitreous body.
    Kooijman AC; van den Berg W; Blanksma LJ; Siertsema JV
    Doc Ophthalmol; 1982 Jan; 52(3-4):333-7. PubMed ID: 7067600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of fluorescein in the vitreous.
    Palestine AG; Brubaker RF
    Invest Ophthalmol Vis Sci; 1981 Oct; 21(4):542-9. PubMed ID: 7287343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorometric studies on the blood-retinal barrier in experimental animals.
    Krupin T; Waltman SR; Szewczyk P; Koloms B; Farber M; Silverstein B; Becker B
    Arch Ophthalmol; 1982 Apr; 100(4):631-4. PubMed ID: 6176219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous fluorophotometry in diabetes mellitus.
    Krupin T; Waltman SR; Becker B
    Ophthalmology; 1979 Jan; 86(1):137-41. PubMed ID: 119199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control.
    White NH; Waltman SR; Krupin T; Santiago JV
    Diabetes; 1982 Jan; 31(1):80-5. PubMed ID: 6759217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular fluorophotometry in streptozotocin diabetes mellitus in the rat: effect of pancreatic islet isografts.
    Krupin T; Waltman SR; Scharp DW; Oestrich C; Feldman SD; Becker B; Ballinger WF; Lacy PE
    Invest Ophthalmol Vis Sci; 1979 Nov; 18(11):1185-90. PubMed ID: 116969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular fluorophotometry in the normal- and diabetic monkey.
    Jones CW; Cunha-Vaz JG; Zeimer RC; Rusin MM; Langenberg PW; Vygantas CM; Tso MO; Jonasson O
    Exp Eye Res; 1986 May; 42(5):467-77. PubMed ID: 3720865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular fluorophotometry in normal subjects.
    Kjaergaard JJ
    Int J Microcirc Clin Exp; 1983; 2(3):199-205. PubMed ID: 6678847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitreous fluorophotometry: identification of sources of variability.
    Prager TC; Wilson DJ; Avery GD; Merritt JH; Garcia CA; Hopen G; Anderson RE
    Invest Ophthalmol Vis Sci; 1981 Dec; 21(6):854-64. PubMed ID: 7309436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
    Lund-Andersen H; Krogsaa B; la Cour M; Larsen J
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular fluorophotometry in patients with essential hypertension.
    Kayazawa F; Miyake K
    Arch Ophthalmol; 1984 Aug; 102(8):1169-70. PubMed ID: 6466180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-ocular barrier permeability in monkeys.
    Yoshida A; Ishiko S; Kojima M; Lipsky SN
    Br J Ophthalmol; 1992 Feb; 76(2):84-7. PubMed ID: 1739721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorophotometric evaluation of the blood-ocular barrier function following cataract surgery and intraocular lens implantation.
    Miyake K
    J Cataract Refract Surg; 1988 Sep; 14(5):560-8. PubMed ID: 3054055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous fluorophotometry evaluation of xenon photocoagulation.
    Noth JM; Vygantas C; Cunha-Vaz JG
    Invest Ophthalmol Vis Sci; 1978 Dec; 17(12):1206-9. PubMed ID: 721394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of fluorescein glucuronide and its metabolism in vitreous fluorophotometry.
    Plehwe WE; Chahal PS; Fallon TJ; Cunningham JR; Neal MJ; Kohner EM
    Exp Eye Res; 1987 Feb; 44(2):209-15. PubMed ID: 3582508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior vitreous fluorophotometry. I. Description of a new analysis procedure and results in normal subjects.
    Bungay PM; Roy MS; Bonner RF
    Arch Ophthalmol; 1989 Sep; 107(9):1321-7. PubMed ID: 2783065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.